Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Scalp hair cortisol and testosterone levels in patients with sarcoidosis.

van Manen MJG, Wester VL, van Rossum EFC, van den Toorn LM, Dorst KY, de Rijke YB, Wijsenbeek MS.

PLoS One. 2019 Jun 14;14(6):e0215763. doi: 10.1371/journal.pone.0215763. eCollection 2019.

2.

Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners.

Moor CC, van Manen MJG, van Hagen PM, Miedema JR, van den Toorn LM, Gür-Demirel Y, Berendse APC, van Laar JAM, Wijsenbeek MS.

Lung. 2018 Oct;196(5):569-575. doi: 10.1007/s00408-018-0144-4. Epub 2018 Aug 7.

3.

Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis.

Heukels P, van Hulst JAC, van Nimwegen M, Boorsma CE, Melgert BN, van den Toorn LM, Boomars KAT, Wijsenbeek MS, Hoogsteden H, von der Thüsen JH, Hendriks RW, Kool M, van den Blink B.

Respir Res. 2018 May 10;19(1):90. doi: 10.1186/s12931-018-0798-8.

4.

Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis.

Broos CE, Wapenaar M, Looman CWN, In 't Veen JCCM, van den Toorn LM, Overbeek MJ, Grootenboers MJJH, Heller R, Mostard RL, Poell LHC, Hoogsteden HC, Kool M, Wijsenbeek MS, van den Blink B.

Eur Respir J. 2018 Jan 18;51(1). pii: 1702089. doi: 10.1183/13993003.02089-2017. Print 2018 Jan. No abstract available.

5.

No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis.

Broos CE, Poell LHC, Looman CWN, In 't Veen JCCM, Grootenboers MJJH, Heller R, van den Toorn LM, Wapenaar M, Hoogsteden HC, Kool M, Wijsenbeek MS, van den Blink B.

Respir Med. 2018 May;138S:S31-S37. doi: 10.1016/j.rmed.2017.10.022. Epub 2017 Oct 31.

PMID:
29137908
6.

Lung Transplantation in Gaucher Disease: A Learning Lesson in Trying to Avoid Both Scylla and Charybdis.

de Boer GM, van Dussen L, van den Toorn LM, den Bakker MA, Hoek RA, Hesselink DA, Hollak CE, van Hal PT.

Chest. 2016 Jan;149(1):e1-5. doi: 10.1016/j.chest.2015.09.011. Epub 2016 Jan 6.

PMID:
26757299
7.

[Idiopathic pulmonary fibrosis: new insights].

Kraan JW, van den Blink B, van den Toorn LM, Bresser P, van Beek FT, Grutters JC, Wijsenbeek MS.

Ned Tijdschr Geneeskd. 2015;159:A8148. Review. Dutch.

PMID:
25654681
8.

"Tree in bud" attributable to organising pneumonia.

Bots EM, den Bakker MA, Wijsenbeek MS, van den Toorn LM, van den Blink B.

Thorax. 2013 Apr;68(4):399-400. doi: 10.1136/thoraxjnl-2012-202064. Epub 2012 Jul 27. No abstract available.

PMID:
22843557
9.

WITHDRAWN: Predictors of long-term survival in pulmonary hypertension treated with bosentan.

Bresser P, Vis JC, Berger RM, Vliegen HW, Vonk MC, Snijder RJ, van den Toorn LM, van Dijk AP, Boomars KA, van Daal GJ, Mulder BJ.

J Heart Lung Transplant. 2011 Mar 17. [Epub ahead of print]

PMID:
21414807
10.

The pressure mounts on lung dendritic cells.

Lambrecht BN, van den Toorn LM.

Eur Respir J. 2007 Mar;29(3):435-7. No abstract available.

11.

Nasal nitric oxide in cystic fibrosis with and without humming.

Struben VM, Sewbalak WV, Wieringa MH, Mantingh CJ, van den Toorn LM, Bakker M, Feenstra L, de Jongste JC.

Eur J Clin Invest. 2007 Feb;37(2):140-4.

PMID:
17217380
12.

Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter.

van den Toorn LM, Schaap E, Surmont VF, Pouw EM, van der Rijt KC, van Klaveren RJ.

Lung Cancer. 2005 Oct;50(1):123-7.

PMID:
15998551
13.

Benefit from anti-inflammatory treatment during clinical remission of atopic asthma.

van den Toorn LM, Prins JB, de Jongste JC, Leman K, Mulder PG, Hoogsteden HC, Overbeek SE.

Respir Med. 2005 Jun;99(6):779-87. Epub 2005 Jan 12.

14.

Clinical implications of airway inflammation in mild intermittent asthma.

van den Toorn LM.

Ann Allergy Asthma Immunol. 2004 Jun;92(6):589-94; quiz 595-7, 658. Review.

PMID:
15237759
15.

Asthma remission: does it exist?

van den Toorn LM, Overbeek SE, Prins JB, Hoogsteden HC, de Jongste JC.

Curr Opin Pulm Med. 2003 Jan;9(1):15-20. Review.

PMID:
12476079
16.

Dyspnoea perception during clinical remission of atopic asthma.

van den Toorn LM, Overbeek SE, Prins JB, Hoogsteden HC, De Jongste JC.

Eur Respir J. 2002 Jun;19(6):1047-50.

17.

Airway inflammation is present during clinical remission of atopic asthma.

van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB.

Am J Respir Crit Care Med. 2001 Dec 1;164(11):2107-13. Erratum in: Am J Respir Crit Care Med. 2002 Oct 15;166(8):1143.

PMID:
11739143
18.

Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness.

van Den Toorn LM, Prins JB, Overbeek SE, Hoogsteden HC, de Jongste JC.

Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):953-7.

PMID:
10988112

Supplemental Content

Loading ...
Support Center